Given that heliomycin was previously reported to target and downregulate SIRT1 in bladder cancer cells (Lin et al., 2022), in this present study, we addressed the question of SIRT1 inhibition by 4-dmH and its associated molecular events. The gene discussed is SIRT1; the disease is urinary bladder cancer.